Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-26 Lindborg Stacy Director Grant or award · Stock Option (Right to Buy) +150,000 $0.70 $105K 150,000
2025-01-01 Lindborg Stacy Director Grant or award +20,000 48,229
2024-03-11 Lindborg Stacy Co-Chief Executive Officer Grant or award +241,935 423,435
2023-09-01 Lindborg Stacy Co-Chief Executive Officer Purchase +11,500 $1.77 $20K 181,500
2023-08-02 Lindborg Stacy Co-Chief Executive Officer Grant or award +35,000 170,000
2023-04-20 Lindborg Stacy Co-Chief Executive Officer Grant or award +75,000 135,000
2022-12-07 Lindborg Stacy Co-Chief Executive Officer Grant or award +35,000 60,000
2020-11-17 Lindborg Stacy EVP, Head Global Clin Research Purchase · Call Option (right to buy) +200 $11,000.00 $2.2M 200
2020-06-01 Lindborg Stacy EVP, Head Global Clin Research Grant or award +25,000 25,000
2020-06-01 Lindborg Stacy EVP, Head Global Clin Research Grant or award · Stock Option (right to buy) +100,000 100,000

Page 1 of 1 · 10 trades